Progressive multifocal leukoencephalopathy: Difference between revisions

Jump to navigation Jump to search
WikiBot (talk | contribs)
No edit summary
WikiBot (talk | contribs)
Line 33: Line 33:
==Treatment==
==Treatment==
[[Progressive multifocal leukoencephalopathy medical therapy|Medical Therapy]] | [[Progressive multifocal leukoencephalopathy surgery|Surgery]] | [[Progressive multifocal leukoencephalopathy primary prevention|Primary Prevention]] | [[Progressive multifocal leukoencephalopathy secondary prevention|Secondary Prevention]]  ''' '''
[[Progressive multifocal leukoencephalopathy medical therapy|Medical Therapy]] | [[Progressive multifocal leukoencephalopathy surgery|Surgery]] | [[Progressive multifocal leukoencephalopathy primary prevention|Primary Prevention]] | [[Progressive multifocal leukoencephalopathy secondary prevention|Secondary Prevention]]  ''' '''
'''==References==
'''
==References==
* Aksamit, A. J. (2001) Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosin arabinoside. J Neurovirol 2001;7:386.  
* Aksamit, A. J. (2001) Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosin arabinoside. J Neurovirol 2001;7:386.  
* Berger, J.R. (2003) Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions. ''Journal of Neurovirology'' '''9''' (supplement), 38-41. PMID 12709870
* Berger, J.R. (2003) Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions. ''Journal of Neurovirology'' '''9''' (supplement), 38-41. PMID 12709870

Revision as of 23:36, 7 February 2012

Template:DiseaseDisorder infobox


Progressive multifocal leukoencephalopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Progressive multifocal leukoencephalopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Progressive multifocal leukoencephalopathy On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Progressive multifocal leukoencephalopathy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Progressive multifocal leukoencephalopathy

CDC on Progressive multifocal leukoencephalopathy

Progressive multifocal leukoencephalopathy in the news

Blogs on Progressive multifocal leukoencephalopathy

Progressive multifocal leukoencephalopathy

Risk calculators and risk factors for Progressive multifocal leukoencephalopathy

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Classification

Historical Perspective

Pathophysiology

Epidemiology & Demographics

Risk Factors

Screening

Causes

Differentiating Progressive multifocal leukoencephalopathy from other Diseases

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms | Physical Examination | Staging | Lab Tests | Electrocardiogram |Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention

References

  • Aksamit, A. J. (2001) Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosin arabinoside. J Neurovirol 2001;7:386.
  • Berger, J.R. (2003) Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions. Journal of Neurovirology 9 (supplement), 38-41. PMID 12709870
  • Langer-Gould, A., Atlas, S. W., Bollen, A. W., Pelletier, D. (2005) Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab. N Engl J Med 2005;353:375-81.
  • Vendrely, A., Bienvenu, B., Gasnault, J., Thiebault, J.B., Salmon, D. and Gray, F. (2005) Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathologica 109, 449-455. PMID 15739098
  • Wyen, C., Hoffmann, C., Schmeisser, N., Wohrmann, A., Qurishi, N., Rockstroh, J., Esser, S., Rieke, A., Ross, B., Lorenzen, T., Schmitz, K., Stenzel, W., Salzberger, B. and Fatkenheuer, G. (2004) Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death. Journal of Acquired Immune Deficiency Syndrome 37, 1263-1268. PMID 15385733

See also

Template:Viral diseases de:Progressive multifokale Leukenzephalopathie nl:Progressieve multifocale leukoencefalopathie


Template:WikiDoc Sources